We are live on
!
Find out more
Russell Investments Group Portfolio holdings
AUM
$114B
1-Year Est. Return
41.71%
This Fund
S&P 500
This Quarter
Est. Return
+12.88%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$56.2B
AUM Growth
+$5.69B
(+11%)
Cap. Flow
-$410M
Cap. Flow
% of AUM
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
19.08%
Holding
3,692
New
183
Increased
1,286
Reduced
1,419
Closed
493
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$92.4M |
| 2 |
Sun Communities
SUI
|
+$68.7M |
| 3 |
Amazon
AMZN
|
+$68.5M |
| 4 |
Humana
HUM
|
+$62M |
| 5 |
APO.PRA
Apollo Global Management Series A
APO.PRA
|
+$51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$235M |
| 2 |
Microsoft
MSFT
|
+$51.7M |
| 3 |
Prologis
PLD
|
+$47.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$47.3M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.24% |
| 2 | Financials | 13% |
| 3 | Healthcare | 11.64% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Real Estate | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNCR
2676
DELISTED
Synchronoss Technologies
SNCR
| $15.9K | ﹤0.01% |
2,555
-1
| -0% | -$5 |
|
2677
Piper Sandler
PIPR
$5.55B
| $15.7K | ﹤0.01% |
360
-37,632
| -99% | -$1.43M |
|
|
MRTX
2678
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.6K | ﹤0.01% |
266
-5,329
| -95% | -$300K |
|
2679
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $15.6K | ﹤0.01% |
125
-98
| -44% | -$11.5K |
|
2680
Lemonade
LMND
$4.14B
| $15.6K | ﹤0.01% |
965
-1,205
| -56% | -$18.2K |
|
2681
Eagle Bancorp
EGBN
$882M
| $15.5K | ﹤0.01% |
515
+152
| +42% | +$3.59K |
|
|
UNIT
2682
Uniti Group
UNIT
$2.39B
| $15.4K | ﹤0.01% |
2,668
-13,928
| -84% | -$70.6K |
|
2683
ORIX
IX
$43.9B
| $15.4K | ﹤0.01% |
825
-3,265
| -80% | -$59.4K |
|
|
APLS
2684
DELISTED
Apellis Pharmaceuticals
APLS
| $15.3K | ﹤0.01% |
256
-35,215
| -99% | -$1.79M |
|
2685
Atea Pharmaceuticals
AVIR
$403M
| $15K | ﹤0.01% |
4,910
+241
| +5% | +$730 |
|
2686
Mission Produce
AVO
$1.15B
| $14.8K | ﹤0.01% |
+1,470
| New | +$13.7K |
|
|
CMBM
2687
DELISTED
Cambium Networks
CMBM
| $14.6K | ﹤0.01% |
2,440
+559
| +30% | +$2.75K |
|
|
MACK
2688
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $14.3K | ﹤0.01% |
1,066
+202
| +23% | +$2.55K |
|
2689
Liberty Broadband Class A
LBRDA
$5.28B
| $14.1K | ﹤0.01% |
175
-13
| -7% | -$1.09K |
|
2690
iShares MSCI USA Value Factor ETF
VLUE
$9.72B
| $14.1K | ﹤0.01% |
139
| – | – |
|
2691
Riley Exploration Permian
REPX
$786M
| $14.1K | ﹤0.01% |
+516
| New | +$14.6K |
|
2692
SGHC Ltd
SGHC
$6.64B
| $13.9K | ﹤0.01% |
+4,383
| New | +$14.7K |
|
2693
Prothena Corp
PRTA
$465M
| $13.9K | ﹤0.01% |
+382
| New | +$14.7K |
|
|
GPMT
2694
Granite Point Mortgage Trust
GPMT
$58.8M
| $13.7K | ﹤0.01% |
2,298
+1,044
| +83% | +$5.26K |
|
2695
Bakkt Inc
BKKT
$332M
| $13.6K | ﹤0.01% |
+244
| New | +$8.45K |
|
|
CDTX
2696
DELISTED
Cidara Therapeutics
CDTX
| $13.6K | ﹤0.01% |
855
| – | – |
|
2697
Jack in the Box
JACK
$357M
| $13.6K | ﹤0.01% |
166
+29
| +21% | +$2.05K |
|
2698
Globalstar
GSAT
$10.7B
| $13.5K | ﹤0.01% |
466
| – | – |
|
2699
Agios Pharmaceuticals
AGIO
$1.99B
| $13.4K | ﹤0.01% |
604
-1,639
| -73% | -$36.7K |
|
2700
iShares MSCI Australia ETF
EWA
$1.45B
| $13.3K | ﹤0.01% |
547
-5
| -0.9% | -$111 |
|
Similar funds
VAM
Russell Investments Group's Q4 2023 Portfolio in Review
As of Q4 2023, Russell Investments Group held 3,692 positions worth $56.2B, up 11% from $50.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Russell Investments Group's Q4 2023 filing shows 183 new, 1,286 increased, 1,419 reduced and 493 closed positions. Its largest new stake was Veralto: 542,517 shares worth $44.6M. The largest sale was Bank of America Series L, an estimated $235M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Russell Investments Group's largest Q4 2023 buy was Veralto: 542,517 shares worth $44.6M.
- Russell Investments Group added most to Apple in Q4 2023, an estimated $92.4M increase.
- Russell Investments Group's biggest Q4 2023 reduction was Bank of America Series L, cutting an estimated $235M.
- Russell Investments Group fully exited Televisa in Q4 2023, selling an estimated $16.6M.
- Russell Investments Group's ten largest holdings make up 19% of its $56.2B portfolio in Q4 2023.
- Russell Investments Group opened 183 new positions and closed 493 in Q4 2023.
- Russell Investments Group's portfolio value rose 11% quarter-over-quarter to $56.2B.
Based on Russell Investments Group's 13F filing for Q4 2023, filed 5 Feb 2024.